Antimalarial drug use among caregivers in Ghana
- PMID: 15687069
- PMCID: PMC2688325
Antimalarial drug use among caregivers in Ghana
Abstract
Background: Chloroquine remains the first line antimalarial drug in Ghana. However, the emergence of Plasmodium falciparum resistance to chloroquine is a major obstacle to the national control strategy of case management. This study provides information on some of the reasons underlying chloroquine treatment failure in the country.
Methodology: Household surveys, using multi-stage sampling, were conducted in 2 sentinel districts, Wassa West and Kassena Nankana, established to monitor chloroquine resistance in the country. Five hundred caregivers were interviewed in each district to determine patterns of antimalarial drug use among caregivers of children under 10 years. Inventory on home-kept drugs was conducted.
Results: Two hundred and four households in the Wassa West district kept a cumulative total of 248 drugs, whereas 228 households in the Kassena Nankana district kept a cumulative total of 410 drugs. One hundred and ninety-nine (80.2%) of the drugs kept in the Wassa West district and 181 (44.2%) of drugs kept in the Kassena Nankana district were antimalarials. The most commonly kept antimalarial drug in homes was chloroquine (88% and 96% in the Wassa West and Kassena Nankana districts respectively). Reasons given for keeping antimalarials were mainly "leftover after previous treatment". Caregivers' descriptions of the amount of chloroquine given to family members suspected to have malaria within the 2-week period preceding the survey were mostly inappropriate in the 2 districts. However, the proportion of appropriateness of doses was significantly lower in the Wassa West district (11.1% vs 36.4%; p < 0.0001).
Conclusions: The significantly higher proportion of inappropriateness of chloroquine use in the Wassa West district could be a factor influencing the lower sensitivity of Plasmodium falciparum to chloroquine in the district compared to the Kassena Nankana district.
Similar articles
-
Antimalarial prescribing practices: a challenge to malaria control in Ghana.Med Princ Pract. 2005 Sep-Oct;14(5):332-7. doi: 10.1159/000086931. Med Princ Pract. 2005. PMID: 16103699
-
Factors associated with appropriate home management of uncomplicated malaria in children in Kassena-Nankana district of Ghana and implications for community case management of childhood illness: a cross-sectional study.BMC Public Health. 2015 May 2;15:458. doi: 10.1186/s12889-015-1777-3. BMC Public Health. 2015. PMID: 25934315 Free PMC article.
-
Chloroquine-resistant Plasmodium falciparum local strain in Taiz Governorate, Republic of Yemen.Chemotherapy. 2006;52(4):166-70. doi: 10.1159/000093592. Epub 2006 May 24. Chemotherapy. 2006. PMID: 16720983
-
Withdrawing antimalarial drugs: impact on parasite resistance and implications for malaria treatment policies.Drug Resist Updat. 2004 Aug-Oct;7(4-5):279-88. doi: 10.1016/j.drup.2004.08.003. Drug Resist Updat. 2004. PMID: 15533765 Review.
-
From methylene blue to chloroquine: a brief review of the development of an antimalarial therapy.Parasitol Res. 2012 Jul;111(1):1-6. doi: 10.1007/s00436-012-2886-x. Epub 2012 Mar 13. Parasitol Res. 2012. PMID: 22411634 Review.
Cited by
-
The use of non-prescribed anti-malarial drugs for the treatment of malaria in the Bolgatanga municipality, northern Ghana.Malar J. 2013 Jul 31;12:266. doi: 10.1186/1475-2875-12-266. Malar J. 2013. PMID: 23902654 Free PMC article.
-
Concurrence of Plasmodium falciparum dhfr and crt mutations in northern Ghana.Malar J. 2005 Sep 15;4:42. doi: 10.1186/1475-2875-4-42. Malar J. 2005. PMID: 16164748 Free PMC article.
-
Large-scale surveillance of Plasmodium falciparum crt(K76T) in northern Ghana.Antimicrob Agents Chemother. 2007 Sep;51(9):3407-9. doi: 10.1128/AAC.00179-07. Epub 2007 Jun 11. Antimicrob Agents Chemother. 2007. PMID: 17562799 Free PMC article.
-
Use of over-the-counter malaria medicines in children and adults in three districts in Kenya: implications for private medicine retailer interventions.Malar J. 2007 May 10;6:57. doi: 10.1186/1475-2875-6-57. Malar J. 2007. PMID: 17493270 Free PMC article.
-
Prevalence of antimalaria drug resistance-conferring mutations associated with sulphadoxine-pyrimethamineine-resistant Plasmodium falciparum in East Africa: a systematic review and meta-analysis.Ann Clin Microbiol Antimicrob. 2025 Apr 16;24(1):25. doi: 10.1186/s12941-025-00795-7. Ann Clin Microbiol Antimicrob. 2025. PMID: 40241183 Free PMC article.
References
-
- World Health Organization, author. The World Health Report 1999. Making a Difference. Geneva: World Health Organization; 1999.
-
- Ghana Ministry of Health, author. Draft, Roll Back Malaria Strategic Plan for Ghana: 2000–2010. Accra: Ministry of Health; 1999.
-
- Snow RW, Peshu N, Forster D, Mwenesi H, Marsh K. The role of shops in the treatment and prevention of childhood malaria on the coast of Kenya. Transactions of the Royal Society of Tropical Medicine and Hygiene. 1992;86(3):237–239. - PubMed
-
- Foster S. Treatment of malaria outside the formal health services. Journal of Tropical Medicine and Hygiene. 1995;98(1):29–34. - PubMed
-
- McCombie SC. Treatment seeking for malaria: a review of recent research. Social Science and Medicine. 1996;43(6):933–945. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical